Company
Lilly
39 published works
Budding Trends
Trip Advisor: FDA Publishes Guidance on Psychedelic Drug Trials
By Slates C. Veazey, Hillary Campbell
We've been waiting on this one for three years. If you've frequented this blog, you know three years is basically an eternity in Food and Drug Administration (FDA) years but…
In-House Ops
Goodwin’s Life Sciences Deal Flow Points to a More Selective M&A Market
By Corporate Counsel Business Journal
Life sciences M&A is back, but not as a free-for-all.Goodwin positions itself around a clear 2026 market signal: Life sciences M&A has reemerged as a competitive arena after a quieter…
Your ERISA Watch
Your ERISA Watch – Week of November 19, 2025
This week we are reporting on twice as many cases as last week, which sounds like a lot! Unfortunately, there were only three cases in last week’s edition, so suddenly…
Roberts Disability Law Blog
District Court Upholds Denial of Severance Benefits Based on Expense Report “Misconduct”
In Cella v. Lilly Usa LLC & The Lilly Severance Pay Plan, No. 1:24-CV-00814-TWP-MKK, 2025 WL 3134607 (S.D. Ind. Nov. 10, 2025), the U.S. District Court for the Southern District…
Nonprofit Law Prof Blog
2023 Global Philanthropy Tracker Reports $70 Billion in 2020 Cross-Border Philanthropy
The Lilly Family School of Philanthropy at IUPUI has published the 2023 Global Philanthropy Tracker. Its key findings include:In 2020, 47 countries representing 61 percent of the global population and…
Nonprofit Law Prof Blog
April 8th: Charitable Crowdfunding: Who Give, to What, and Why? (Lilly Family School of Philanthropy)
I am very much looking forward to participating in a presentation with Amy Sample Ward and Una Osili on new research from the Lilly Family School of Philanthropy about charitable…
Nonprofit Law Prof Blog
Strong Fundraising Years Ahead Despite Pandemic
As reported in The Chronicle of Philanthropy, the Lilly Family School of Philanthropy recent report predicts a period of “broad philanthropic growth” is forthcoming the next two years as the…
Big Molecule Watch
FDA Approves LYUMJEV (insulin lispro-aabc injection)
This week, the FDA approved LYUMJEV (insulin lispro-aabc), a new insulin lispro product by Lilly. LYUMJEV is a formulation of insulin lispro, developed to speed the absorption of insulin into…
Big Molecule Watch
COVID-19 Pandemic May Impact Biosimilars
The COVID-19 pandemic has introduced new challenges for the pharmaceutical industry, including makers of biosimilars. In response, the FDA has asked pharmaceutical makers to closely monitor their supply chains and…
Life Sciences Legal Insights
Biotech & Life Sciences Trends to Consider Following JPM 2020: M&A, Venture Capital and More
The annual gathering of life sciences executives and investors in San Francisco that many now call “JPM Week” recently concluded, marking the J.P. Morgan Healthcare Conference’s 38th year. The Big…